Evaluation of QOL for stem cell transplantation recipients by SF-36 and FACT-BMT: Preliminary results of FACT-BMT for Japanese patients

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 5, 2010, Pages 847-851

  Imataki, Osamu ^a   Nakajima, Kazuko ^a   Inoue, Naomi ^a   Tamai, Yotaro ^a   Kawakami, Kimihiro ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

FACT BMT; Quality of life (QOL); SF 36; Stem cell transplantation (SCT)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY PAIN; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EMOTION; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BONE MARROW TRANSPLANT; GRAFT RECIPIENT; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; INTERNAL VALIDITY; JAPAN; JAPANESE; MALE; MEDICAL OUTCOMES STUDY 36 ITEM SHORT FORM 36; MENTAL HEALTH; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL INTERACTION; T CELL LEUKEMIA;

EID: 79960765257     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Coons SJ, Rao S, Keininger DL, et al: A comparative review of generic quality-of-life instruments. Pharmacoeconomics 17(1):13-35, 2000. (Pubitemid 30072853)
2. Sanders C, Egger M, Donovan J, et al: Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 317(7167):1191-1194, 1998. (Pubitemid 28488508)
3. Thomas ED: Kamofsky Memorial Lecture. Marrow transplantation for malignant diseases. J Clin Oncol 1(9):517-531, 1983.
4. Duell T, van Lint MT, Ljungman P, et al: Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 126(3):184-192, 1997.
5. Socie G, Stone JV, Wingard JR, et al: Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341(1):14-21, 1999.
6. Lee SJ, Kim HT, Ho VT, et al: Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 38(4):305-310, 2006. (Pubitemid 44203780)
7. Naito M, Nakayama T and Fukuhara S: Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan. Health Qual Life Outcomes 2:31, 2004.
8. Fukuhara S, Bito S, Green J, et al: Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51(11):1037-1044, 1998. (Pubitemid 28527159)
9. McQuellon RP, Russell GB, Cella DF, et al: Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357-368, 1997. (Pubitemid 27096068)
10. Fukuhara S, Ware JE Jr, Kosinski M, et al: Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51(11):1045-1053, 1998. (Pubitemid 28527160)
11. Hensel M, Egerer G, Schneeweiss A, et al: Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol 13(2):209-217, 2002. (Pubitemid 34704971)
12. Worel N, Biener D, Kalhs P, et al: Long-term outcome and quality of life of patients who are alive and in complete remis2 sion more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30(9):619-626, 2002.
13. Detmar SB, Muller MJ, Schornagel JH, et al: Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288(23):3027-3034, 2002.